Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Immunology Drug market report explains the definition, types, applications, major countries, and major players of the Immunology Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
F Hoffmann-La Roche Ltd
Seattle Genetics
Sanofi Aventis LLC
Pfizer
Abbott Laboratories
Active Biotech
Autoimmune Inc
Bayer AG
GlaxoSmithKline plc
Eli Lilly and Company
Genentech
Eisai Co
By Type:
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
By End-User:
Hospitals
Clinics
Cancer Research Centers and Institutes
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Immunology Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Immunology Drug Outlook to 2028- Original Forecasts
-
2.2 Immunology Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Immunology Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Immunology Drug Market- Recent Developments
-
6.1 Immunology Drug Market News and Developments
-
6.2 Immunology Drug Market Deals Landscape
7 Immunology Drug Raw Materials and Cost Structure Analysis
-
7.1 Immunology Drug Key Raw Materials
-
7.2 Immunology Drug Price Trend of Key Raw Materials
-
7.3 Immunology Drug Key Suppliers of Raw Materials
-
7.4 Immunology Drug Market Concentration Rate of Raw Materials
-
7.5 Immunology Drug Cost Structure Analysis
-
7.5.1 Immunology Drug Raw Materials Analysis
-
7.5.2 Immunology Drug Labor Cost Analysis
-
7.5.3 Immunology Drug Manufacturing Expenses Analysis
8 Global Immunology Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Immunology Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Immunology Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Immunology Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Immunology Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies (mAb) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Interferon and Cytokine therapies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immunosuppressive medication Consumption and Growth Rate (2017-2022)
-
9.2 Global Immunology Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cancer Research Centers and Institutes Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Immunology Drug Market Analysis and Outlook till 2022
-
10.1 Global Immunology Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Immunology Drug Consumption (2017-2022)
-
10.2.2 Canada Immunology Drug Consumption (2017-2022)
-
10.2.3 Mexico Immunology Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Immunology Drug Consumption (2017-2022)
-
10.3.2 UK Immunology Drug Consumption (2017-2022)
-
10.3.3 Spain Immunology Drug Consumption (2017-2022)
-
10.3.4 Belgium Immunology Drug Consumption (2017-2022)
-
10.3.5 France Immunology Drug Consumption (2017-2022)
-
10.3.6 Italy Immunology Drug Consumption (2017-2022)
-
10.3.7 Denmark Immunology Drug Consumption (2017-2022)
-
10.3.8 Finland Immunology Drug Consumption (2017-2022)
-
10.3.9 Norway Immunology Drug Consumption (2017-2022)
-
10.3.10 Sweden Immunology Drug Consumption (2017-2022)
-
10.3.11 Poland Immunology Drug Consumption (2017-2022)
-
10.3.12 Russia Immunology Drug Consumption (2017-2022)
-
10.3.13 Turkey Immunology Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Immunology Drug Consumption (2017-2022)
-
10.4.2 Japan Immunology Drug Consumption (2017-2022)
-
10.4.3 India Immunology Drug Consumption (2017-2022)
-
10.4.4 South Korea Immunology Drug Consumption (2017-2022)
-
10.4.5 Pakistan Immunology Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Immunology Drug Consumption (2017-2022)
-
10.4.7 Indonesia Immunology Drug Consumption (2017-2022)
-
10.4.8 Thailand Immunology Drug Consumption (2017-2022)
-
10.4.9 Singapore Immunology Drug Consumption (2017-2022)
-
10.4.10 Malaysia Immunology Drug Consumption (2017-2022)
-
10.4.11 Philippines Immunology Drug Consumption (2017-2022)
-
10.4.12 Vietnam Immunology Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Immunology Drug Consumption (2017-2022)
-
10.5.2 Colombia Immunology Drug Consumption (2017-2022)
-
10.5.3 Chile Immunology Drug Consumption (2017-2022)
-
10.5.4 Argentina Immunology Drug Consumption (2017-2022)
-
10.5.5 Venezuela Immunology Drug Consumption (2017-2022)
-
10.5.6 Peru Immunology Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Immunology Drug Consumption (2017-2022)
-
10.5.8 Ecuador Immunology Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Immunology Drug Consumption (2017-2022)
-
10.6.2 Kuwait Immunology Drug Consumption (2017-2022)
-
10.6.3 Oman Immunology Drug Consumption (2017-2022)
-
10.6.4 Qatar Immunology Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Immunology Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Immunology Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Immunology Drug Consumption (2017-2022)
-
10.7.2 South Africa Immunology Drug Consumption (2017-2022)
-
10.7.3 Egypt Immunology Drug Consumption (2017-2022)
-
10.7.4 Algeria Immunology Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Immunology Drug Consumption (2017-2022)
-
10.8.2 New Zealand Immunology Drug Consumption (2017-2022)
11 Global Immunology Drug Competitive Analysis
-
11.1 F Hoffmann-La Roche Ltd
-
11.1.1 F Hoffmann-La Roche Ltd Company Details
-
11.1.2 F Hoffmann-La Roche Ltd Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 F Hoffmann-La Roche Ltd Immunology Drug Main Business and Markets Served
-
11.1.4 F Hoffmann-La Roche Ltd Immunology Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Seattle Genetics
-
11.2.1 Seattle Genetics Company Details
-
11.2.2 Seattle Genetics Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Seattle Genetics Immunology Drug Main Business and Markets Served
-
11.2.4 Seattle Genetics Immunology Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sanofi Aventis LLC
-
11.3.1 Sanofi Aventis LLC Company Details
-
11.3.2 Sanofi Aventis LLC Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sanofi Aventis LLC Immunology Drug Main Business and Markets Served
-
11.3.4 Sanofi Aventis LLC Immunology Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Pfizer
-
11.4.1 Pfizer Company Details
-
11.4.2 Pfizer Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Pfizer Immunology Drug Main Business and Markets Served
-
11.4.4 Pfizer Immunology Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Abbott Laboratories
-
11.5.1 Abbott Laboratories Company Details
-
11.5.2 Abbott Laboratories Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Abbott Laboratories Immunology Drug Main Business and Markets Served
-
11.5.4 Abbott Laboratories Immunology Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Active Biotech
-
11.6.1 Active Biotech Company Details
-
11.6.2 Active Biotech Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Active Biotech Immunology Drug Main Business and Markets Served
-
11.6.4 Active Biotech Immunology Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Autoimmune Inc
-
11.7.1 Autoimmune Inc Company Details
-
11.7.2 Autoimmune Inc Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Autoimmune Inc Immunology Drug Main Business and Markets Served
-
11.7.4 Autoimmune Inc Immunology Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bayer AG
-
11.8.1 Bayer AG Company Details
-
11.8.2 Bayer AG Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bayer AG Immunology Drug Main Business and Markets Served
-
11.8.4 Bayer AG Immunology Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GlaxoSmithKline plc
-
11.9.1 GlaxoSmithKline plc Company Details
-
11.9.2 GlaxoSmithKline plc Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GlaxoSmithKline plc Immunology Drug Main Business and Markets Served
-
11.9.4 GlaxoSmithKline plc Immunology Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Eli Lilly and Company
-
11.10.1 Eli Lilly and Company Company Details
-
11.10.2 Eli Lilly and Company Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Eli Lilly and Company Immunology Drug Main Business and Markets Served
-
11.10.4 Eli Lilly and Company Immunology Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Genentech
-
11.11.1 Genentech Company Details
-
11.11.2 Genentech Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Genentech Immunology Drug Main Business and Markets Served
-
11.11.4 Genentech Immunology Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Eisai Co
-
11.12.1 Eisai Co Company Details
-
11.12.2 Eisai Co Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Eisai Co Immunology Drug Main Business and Markets Served
-
11.12.4 Eisai Co Immunology Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Immunology Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Immunology Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Monoclonal Antibodies (mAb) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Interferon and Cytokine therapies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Immunosuppressive medication Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Immunology Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Cancer Research Centers and Institutes Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Immunology Drug Market Analysis and Outlook to 2028
-
13.1 Global Immunology Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Immunology Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Immunology Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Immunology Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Immunology Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Immunology Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Immunology Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Immunology Drug Consumption Forecast (2022-2028)
-
13.3.5 France Immunology Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Immunology Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Immunology Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Immunology Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Immunology Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Immunology Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Immunology Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Immunology Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Immunology Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Immunology Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Immunology Drug Consumption Forecast (2022-2028)
-
13.4.3 India Immunology Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Immunology Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Immunology Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Immunology Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Immunology Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Immunology Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Immunology Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Immunology Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Immunology Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Immunology Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Immunology Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Immunology Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Immunology Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Immunology Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Immunology Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Immunology Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Immunology Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Immunology Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Immunology Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Immunology Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Immunology Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Immunology Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Immunology Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Immunology Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Immunology Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Immunology Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Immunology Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Immunology Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Immunology Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Immunology Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Immunology Drug
-
Figure of Immunology Drug Picture
-
Table Global Immunology Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Immunology Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Monoclonal Antibodies (mAb) Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon and Cytokine therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Immunosuppressive medication Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers and Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Immunology Drug Consumption by Country (2017-2022)
-
Table North America Immunology Drug Consumption by Country (2017-2022)
-
Figure United States Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Immunology Drug Consumption by Country (2017-2022)
-
Figure Germany Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure France Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Immunology Drug Consumption by Country (2017-2022)
-
Figure China Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure India Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table South America Immunology Drug Consumption by Country (2017-2022)
-
Figure Brazil Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Immunology Drug Consumption by Country (2017-2022)
-
Figure Bahrain Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Immunology Drug Consumption by Country (2017-2022)
-
Figure Nigeria Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Immunology Drug Consumption by Country (2017-2022)
-
Figure Australia Immunology Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Immunology Drug Consumption and Growth Rate (2017-2022)
-
Table F Hoffmann-La Roche Ltd Company Details
-
Table F Hoffmann-La Roche Ltd Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Immunology Drug Main Business and Markets Served
-
Table F Hoffmann-La Roche Ltd Immunology Drug Product Portfolio
-
Table Seattle Genetics Company Details
-
Table Seattle Genetics Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Immunology Drug Main Business and Markets Served
-
Table Seattle Genetics Immunology Drug Product Portfolio
-
Table Sanofi Aventis LLC Company Details
-
Table Sanofi Aventis LLC Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Aventis LLC Immunology Drug Main Business and Markets Served
-
Table Sanofi Aventis LLC Immunology Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Immunology Drug Main Business and Markets Served
-
Table Pfizer Immunology Drug Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Immunology Drug Main Business and Markets Served
-
Table Abbott Laboratories Immunology Drug Product Portfolio
-
Table Active Biotech Company Details
-
Table Active Biotech Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Active Biotech Immunology Drug Main Business and Markets Served
-
Table Active Biotech Immunology Drug Product Portfolio
-
Table Autoimmune Inc Company Details
-
Table Autoimmune Inc Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Autoimmune Inc Immunology Drug Main Business and Markets Served
-
Table Autoimmune Inc Immunology Drug Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Immunology Drug Main Business and Markets Served
-
Table Bayer AG Immunology Drug Product Portfolio
-
Table GlaxoSmithKline plc Company Details
-
Table GlaxoSmithKline plc Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Immunology Drug Main Business and Markets Served
-
Table GlaxoSmithKline plc Immunology Drug Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Immunology Drug Main Business and Markets Served
-
Table Eli Lilly and Company Immunology Drug Product Portfolio
-
Table Genentech Company Details
-
Table Genentech Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Immunology Drug Main Business and Markets Served
-
Table Genentech Immunology Drug Product Portfolio
-
Table Eisai Co Company Details
-
Table Eisai Co Immunology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Immunology Drug Main Business and Markets Served
-
Table Eisai Co Immunology Drug Product Portfolio
-
Figure Global Monoclonal Antibodies (mAb) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon and Cytokine therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunosuppressive medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers and Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunology Drug Consumption Forecast by Country (2022-2028)
-
Table North America Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure China Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Immunology Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Immunology Drug Consumption Forecast and Growth Rate (2022-2028)
-
